Article
Concordance between predicted HLA type using next generation sequencing data generated for non-HLA purposes and clinical HLA type.
Human immunology - 1 Aug 2020
Moyer Ann M, Dukek Brian, Duellman Patti, Schneider Brittany, Wakefield Laurie, Skierka Jennifer M, Avula Rajeswari, Bhagwate Aditya V, Kalari Krishna R, Kreuter Justin D, Goetz Matthew P, Boughey Judy C, Black John L, Gandhi Manish J
Abstract excerpt
We explored the feasibility of obtaining accurate HLA type using pre-existing NGS data not generated for HLA purposes. 83 exomes and 500 targeted NGS pharmacogenomic panels were analyzed using Omixon HLA Explore, OptiType, and/or HLA-Genotyper software. Results were compared against clinical HLA genotyping. 765 (94.2%) Omixon and 769 (94.7%) HLA-Genotyper of 812 germline allele calls across class I/II loci and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
